Idiopathic capillary leak syndrome complicated by massive rhabdomyolysis.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 8325053)

Published in Chest on July 01, 1993

Authors

O C Dolberg-Stolik1, C Putterman, A Rubinow, A I Rivkind, C L Sprung

Author Affiliations

1: Department of Anesthesiology/CCM, Hadassah Medical Center, Jerusalem, Israel.

Articles by these authors

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med (1998) 13.94

Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med (1995) 10.29

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med (1991) 9.99

A look into the nature and causes of human errors in the intensive care unit. Crit Care Med (1995) 5.14

Clinical antecedents to in-hospital cardiopulmonary arrest. Chest (1990) 4.94

The ACCP-SCCM consensus conference on sepsis and organ failure. Chest (1992) 4.35

Clinical problem-solving. Still hazy after all these years. N Engl J Med (1994) 2.69

Definitions for sepsis and organ failure. Crit Care Med (1992) 2.69

Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM). Intensive Care Med (2012) 2.49

The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med (1984) 2.37

Plasma cortisol levels in patients with septic shock. Crit Care Med (1990) 2.33

High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med (1987) 2.32

Evaluation of Institutional Review Board review and informed consent in publications of human research in critical care medicine. Crit Care Med (1998) 2.14

Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine. Crit Care Med (2001) 2.12

How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med (1997) 2.03

SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford) (2004) 1.88

Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis (2004) 1.81

Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis (1992) 1.73

Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. Proc Natl Acad Sci U S A (1996) 1.71

Application of SOFA score to trauma patients. Sequential Organ Failure Assessment. Intensive Care Med (1999) 1.66

Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci U S A (1997) 1.61

Localized amyloidosis of the lower respiratory tract. Am Rev Respir Dis (1978) 1.54

The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA (1996) 1.53

Living related donation in lung transplantation. Ethical considerations. Arch Intern Med (1995) 1.53

Pulmonary artery catheterization. Can there be an integrated strategy for guideline development and research promotion? JAMA (1993) 1.51

Why have new effective therapies for sepsis not been developed? Crit Care Med (1994) 1.50

Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol (1987) 1.49

Brucellosis in patients with heart disease: when should endocarditis be diagnosed? Cardiology (1990) 1.46

Blast lung injury from an explosion on a civilian bus. Chest (1999) 1.42

Paracecal hernia: a cause of intestinal obstruction. Dis Colon Rectum (1986) 1.41

B7x/B7-H4 modulates the adaptive immune response and ameliorates renal injury in antibody-mediated nephritis. Clin Exp Immunol (2015) 1.40

Trends in the clinical presentation of temporal arteritis in Israel: reflection of increased physician awareness. Clin Rheumatol (1996) 1.40

HA-1A in septic patients with ARDS: results from the pivotal trial. Intensive Care Med (1994) 1.40

"Treating through" hypersensitivity to co-trimoxazole in AIDS patients. Lancet (1990) 1.40

Acquired immunodeficiency syndrome and critical care. Crit Care Med (1990) 1.39

Progressive systemic sclerosis sine scleroderma in a child presenting as nocturnal seizures and Raynaud's phenomenon. Acta Paediatr (1993) 1.39

Survival of patients with primary (AL) amyloidosis. Colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973). Am J Med (1987) 1.37

Early physiologic predictors of injury severity and death in blunt multiple trauma. Arch Surg (1990) 1.36

Senile cerebral amyloid. Prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion. Am J Pathol (1982) 1.36

Definition of sepsis. Intensive Care Med (2001) 1.34

A look into the nature and causes of human errors in the intensive care unit. 1995. Qual Saf Health Care (2003) 1.31

Digoxin sensitivity in amyloid cardiomyopathy. Circulation (1981) 1.28

ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med (1986) 1.24

Bleeding manifestations in 100 patients with amyloidosis. JAMA (1983) 1.21

Patterns of pulmonary involvement in systemic amyloidosis. Chest (1978) 1.15

Safety of low dose methotrexate in elderly patients with rheumatoid arthritis. Postgrad Med J (2000) 1.12

Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms. Am J Pathol (1984) 1.10

Identification of new SLE-associated genes with a two-step Bayesian study design. Genes Immun (2009) 1.07

Holy consent--a dilemma for medical staff when maternal consent is withheld for emergency caesarean section. Int J Obstet Anesth (2006) 1.07

Respiratory index/pulmonary shunt relationship: quantification of severity and prognosis in the post-traumatic adult respiratory distress syndrome. Crit Care Med (1989) 1.07

Alveolar hemorrhage in cryoglobulinemia--an indicator of poor prognosis. Clin Exp Rheumatol (2005) 1.04

Utility of postmortem computed tomography in trauma victims. J Trauma (1994) 1.04

Hemodynamic alterations of heat stroke in the elderly. Chest (1979) 1.03

Evidence for increased permeability in reexpansion pulmonary edema. Am J Med (1981) 1.03

Is the physician's duty to the individual patient or to society? Crit Care Med (1995) 1.02

The impact of regional culture on intensive care end of life decision making: an Israeli perspective from the ETHICUS study. J Med Ethics (2006) 1.02

Giant cell arteritis in Jerusalem: a 12-year epidemiological study. Br J Rheumatol (1994) 1.01

Ventricular arrhythmias during Swan-Ganz catheterization of the critically ill. Chest (1981) 1.01

Iatrogenic morbidity accompanying suppression of temporal arteritis by adrenal corticosteroids. Ann Ophthalmol (1984) 1.00

Severe intrahepatic cholestasis in primary amyloidosis: a report of four cases and a review of the literature. Am J Med (1978) 0.99

Cyclic anaphylaxis associated with menstruation. Ann Allergy (1991) 0.99

Spontaneous intracerebral hemorrhage in critically ill patients: incidence over six years and associated factors. Intensive Care Med (1999) 0.99

Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome. Clin Rheumatol (1993) 0.99

Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities. J Am Coll Cardiol (1984) 0.98

Relation of colloid osmotic pressure to arterial hypoxemia and cerebral edema during crystalloid volume loading of patients with diabetic ketoacidosis. Ann Intern Med (1982) 0.98

Halofuginone--an inhibitor of collagen type I synthesis--prevents postoperative formation of abdominal adhesions. Ann Surg (1998) 0.98

Polyarteritis nodosa and familial Mediterranean fever: a report of 2 cases and review of the literature. J Rheumatol (1989) 0.98

Gout without crystals on initial synovial fluid analysis. Postgrad Med J (1978) 0.98

HLA antigens in Reiter's syndrome in Israeli patients. J Rheumatol (1985) 0.97

Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Am J Cardiol (1983) 0.97

Reactive arthritis associated with Clostridium difficile pseudomembranous colitis. Semin Arthritis Rheum (1993) 0.96

Foregoing life-sustaining treatment in an Israeli ICU. Intensive Care Med (1998) 0.96

The process of intensive care triage. Intensive Care Med (2001) 0.96

Effects of histamine on bronchial artery blood flow and bronchomotor tone. J Appl Physiol (1985) (1985) 0.95

Acute colchicine intoxication--possible role of erythromycin administration. J Rheumatol (1992) 0.94

The spectrum of pulmonary edema: differentiation of cardiogenic, intermediate, and noncardiogenic forms of pulmonary edema. Am Rev Respir Dis (1981) 0.94

Pulmonary edema; a complication of diabetic ketoacidosis. Chest (1980) 0.93

Orbital mucosa-associated lymphoid tissue (MALT)-type lymphoma in a patient with relapsing polychondritis. Arthritis Rheum (2001) 0.93

Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study. Intensive Care Med (2011) 0.93

Multicentric Castleman's disease associated with rheumatoid arthritis: a possible role of hepatitis B antigen. Ann Rheum Dis (1989) 0.93

Gastrointestinal involvement in homocystinuria. J Gastroenterol Hepatol (1993) 0.92

Studies on the structure, regulation, and pathogenic potential of anti-dsDNA antibodies. Methods (1997) 0.92

Blunt traumatic azygous vein injury diagnosed by computed tomography: case report and review of the literature. J Trauma (2000) 0.90

Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndrome. Chest (1987) 0.90

Heat stroke; modern approach to an ancient disease. Chest (1980) 0.89

Anserine bursitis and non-insulin dependent diabetes mellitus. J Rheumatol (1997) 0.89

The use of oral pilocarpine in xerostomia and Sjögren's syndrome. Semin Arthritis Rheum (1999) 0.88

New technologies, critical care, and economic realities. Crit Care Med (1993) 0.88

End-of-life decision making in the intensive care unit. Intensive Care Med (2000) 0.88

Traumatic macroglossia: a life-threatening complication. Crit Care Med (1999) 0.88

Acute poststreptococcal polymyalgia. Ann Rheum Dis (1986) 0.88

Enzyme immunoassay system for panel testing. Clin Chem (1989) 0.87

Worldwide similarities and differences in the foregoing of life-sustaining treatments. Intensive Care Med (1996) 0.87

Corticosteroids in septic shock: resurrection of the last rites? Crit Care Med (1998) 0.87

Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease. Arch Dermatol (1988) 0.87

The metabolic and respiratory alterations of heat stroke. Arch Intern Med (1980) 0.87

Antigenic triggers and molecular targets for anti-double-stranded DNA antibodies. Lupus (2002) 0.86